Cargando…

Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals

Kryptofix(®) 2.2.2 (Kry) or tetrabutylammonium (TBA) are commonly used as phase transfer catalysts in (18)F-radiopharmaceutical productions for positron emission tomography (PET). Due to their toxicity, quality control has to be performed before administration of the tracer to assure that limit conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuntzsch, Matthias, Lamparter, Denis, Brüggener, Nils, Müller, Marco, Kienzle, Gabriele J., Reischl, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035771/
https://www.ncbi.nlm.nih.gov/pubmed/24830987
http://dx.doi.org/10.3390/ph7050621
_version_ 1782318102717923328
author Kuntzsch, Matthias
Lamparter, Denis
Brüggener, Nils
Müller, Marco
Kienzle, Gabriele J.
Reischl, Gerald
author_facet Kuntzsch, Matthias
Lamparter, Denis
Brüggener, Nils
Müller, Marco
Kienzle, Gabriele J.
Reischl, Gerald
author_sort Kuntzsch, Matthias
collection PubMed
description Kryptofix(®) 2.2.2 (Kry) or tetrabutylammonium (TBA) are commonly used as phase transfer catalysts in (18)F-radiopharmaceutical productions for positron emission tomography (PET). Due to their toxicity, quality control has to be performed before administration of the tracer to assure that limit concentration of residual reagent is not reached. Here, we describe the successful development and pharmaceutical validation (for specificity, accuracy and detection limit) of a simplified color spot test on TLC plates. We were able to prove its applicability as a general, time and resources saving, easy to handle and reliable method in daily routine analyzing (18)F-tracer formulations for Kry (in [(18)F]FDG or [(18)F]FECh) or TBA contaminations (in [(18)F]FLT) with special regard to complex matrix compositions.
format Online
Article
Text
id pubmed-4035771
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-40357712014-05-28 Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals Kuntzsch, Matthias Lamparter, Denis Brüggener, Nils Müller, Marco Kienzle, Gabriele J. Reischl, Gerald Pharmaceuticals (Basel) Article Kryptofix(®) 2.2.2 (Kry) or tetrabutylammonium (TBA) are commonly used as phase transfer catalysts in (18)F-radiopharmaceutical productions for positron emission tomography (PET). Due to their toxicity, quality control has to be performed before administration of the tracer to assure that limit concentration of residual reagent is not reached. Here, we describe the successful development and pharmaceutical validation (for specificity, accuracy and detection limit) of a simplified color spot test on TLC plates. We were able to prove its applicability as a general, time and resources saving, easy to handle and reliable method in daily routine analyzing (18)F-tracer formulations for Kry (in [(18)F]FDG or [(18)F]FECh) or TBA contaminations (in [(18)F]FLT) with special regard to complex matrix compositions. MDPI 2014-05-14 /pmc/articles/PMC4035771/ /pubmed/24830987 http://dx.doi.org/10.3390/ph7050621 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Kuntzsch, Matthias
Lamparter, Denis
Brüggener, Nils
Müller, Marco
Kienzle, Gabriele J.
Reischl, Gerald
Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals
title Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals
title_full Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals
title_fullStr Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals
title_full_unstemmed Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals
title_short Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix(®) 2.2.2 and Tetrabutylammonium in (18)F-Labeled Radiopharmaceuticals
title_sort development and successful validation of simple and fast tlc spot tests for determination of kryptofix(®) 2.2.2 and tetrabutylammonium in (18)f-labeled radiopharmaceuticals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035771/
https://www.ncbi.nlm.nih.gov/pubmed/24830987
http://dx.doi.org/10.3390/ph7050621
work_keys_str_mv AT kuntzschmatthias developmentandsuccessfulvalidationofsimpleandfasttlcspottestsfordeterminationofkryptofix222andtetrabutylammoniumin18flabeledradiopharmaceuticals
AT lamparterdenis developmentandsuccessfulvalidationofsimpleandfasttlcspottestsfordeterminationofkryptofix222andtetrabutylammoniumin18flabeledradiopharmaceuticals
AT bruggenernils developmentandsuccessfulvalidationofsimpleandfasttlcspottestsfordeterminationofkryptofix222andtetrabutylammoniumin18flabeledradiopharmaceuticals
AT mullermarco developmentandsuccessfulvalidationofsimpleandfasttlcspottestsfordeterminationofkryptofix222andtetrabutylammoniumin18flabeledradiopharmaceuticals
AT kienzlegabrielej developmentandsuccessfulvalidationofsimpleandfasttlcspottestsfordeterminationofkryptofix222andtetrabutylammoniumin18flabeledradiopharmaceuticals
AT reischlgerald developmentandsuccessfulvalidationofsimpleandfasttlcspottestsfordeterminationofkryptofix222andtetrabutylammoniumin18flabeledradiopharmaceuticals